While biopharma companies are good with managing direct spend in categories, such as APIs, intermediates and excipients, the neglect of indirect categories such as MRO, IT, travel, marketing, and professional services, often goes unnoticed, despite the negative impacts on enterprise profits.

Learn how GEP helped a $16 billion biopharmaceutical company benefit by advancing beyond the basics in category management and realize $25 million in savings ― exceeding saving target by almost 15 percent.

A not-to-be-missed case study for procurement professionals looking to drive higher value and savings through advanced category management.

RECOMMENDED